Dr. Harris is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
865 Northern Blvd
Ste 203
Great Neck, NY 11021Phone+1 516-708-2540Fax+1 516-708-2573
Education & Training
- Zucker School of Medicine at Hofstra/NorthwellFellowship, Endocrinology, Diabetes, and Metabolism, 2008 - 2010
- Zucker School of Medicine at Hofstra/NorthwellResidency, Internal Medicine, 2002 - 2005
- New York University School of MedicineClass of 2002
Certifications & Licensure
- NY State Medical License 2005 - 2026
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2013
Publications & Presentations
PubMed
- Updates on perioperative cessation of SGLT2 inhibitors.Xiao Q Li, Niloofar Mirsaidi, Jonathan Bauman, Joseph Marino, Yael T Harris
British Journal of Anaesthesia. 2025-03-13 - Pros and Cons of Inpatient SGLT2i Use for Hyperglycemia and Heart Failure.Hayley Fried, Yael Tobi Harris, Rifka Schulman-Rosenbaum
Journal of the Endocrine Society. 2025-01-06 - Culturally Congruent Latino-Adapted Telemonitoring of Underrepresented Adults With Type 2 Diabetes: The CULTURA-DM2 Trial.Renee Pekmezaris, Sabrina Martinez, Valeria Correa Gomez, Jose Marino, Nicole Goris
Clinical Diabetes. 2025-01-01
Press Mentions
- Alzheimer’s Drug Being Studied as Way to Reduce Type 2 Diabetes and Heart Disease RiskJuly 20th, 2017
- Should People Without Diabetes Use Glucose Monitors?August 4th, 2023
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: